Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma

Clinical trial NCT06446154 · RECRUITING

Trial details

NCT number: NCT06446154
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Immune Checkpoint Inhibitors Anti-angiogenic Therapy Second-line Treatment

Start date: 2024-12-27
Primary completion: 2025-12-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.